Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Satellos Bioscience | 2025 | Post-IPO Equity | Undisclosed | Toronto |
| TigerGraph | 2025 | Venture - Series Unknown | Undisclosed | Redwood City |
| Renasant Bio | 2025 | Seed | Undisclosed | Berkeley |
| Elevation Oncology | 2023 | Post-IPO Equity | Undisclosed | New York |
| Leyden Labs | 2026 | Undisclosed | $35.2M | Amsterdam |
| InfStones | 2022 | Series C | Undisclosed | Palo Alto |
| LTZ Therapeutics | 2026 | Venture - Series Unknown | $40.0M | San Francisco |
| BUD | 2022 | Series B | Undisclosed | Singapore |
| Aureka Biotechnologies | 2026 | Series A | $23.4M | Laguna Hills |
| moodytiger | 2023 | Convertible Note | Undisclosed | Hong Kong |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Satellos Bioscience | Post-IPO Equity | Undisclosed | Toronto, Canada |
| 2 | TigerGraph | Venture - Series Unknown | Undisclosed | Redwood City, United States |
| 3 | Renasant Bio | Seed | Undisclosed | Berkeley, United States |
| 4 | Elevation Oncology | Post-IPO Equity | Undisclosed | New York, United States |
| 5 | Leyden Labs | Undisclosed | $35.2M | Amsterdam, The Netherlands |
| 6 | InfStones | Series C | Undisclosed | Palo Alto, United States |
| 7 | LTZ Therapeutics | Venture - Series Unknown | $40.0M | San Francisco, United States |
| 8 | BUD | Series B | Undisclosed | Singapore, Singapore |
| 9 | Aureka Biotechnologies | Series A | $23.4M | Laguna Hills, United States |
| 10 | moodytiger | Convertible Note | Undisclosed | Hong Kong, Hong Kong |
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
TigerGraph supports advanced analytics and machine learning platforms through its distributed native graph database.
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
InfStones provides decentralized blockchain infrastructure service on one integrated platform.
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
BUD is an open metaverse gaming platform that connects millions of virtual worlds created by our community, made up of 9 million creators.
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
moodytiger is a technical athletic apparel brand for children from age of 4 to 16.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Theraheart is a medical device company that offers innovative, minimally invasive solutions for heart failure.
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Fasikl is a neuro-AI company that creates interfaces for the nervous system.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Rhino Federated Computing provides a platform for AI collaboration enterprises to accelerate data strategies and to expand AI use cases.
Soda Health is a healthcare technology company dedicated to eliminating health inequities through social determinants of health.
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
The Clique Compute Coordination Network organizes various heterogeneous compute resources & allocates them efficiently to applications.
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
DeBank creates a cryptocurrency wallet that allows users to access decentralized finance services.
Complete Omics is a developer of multi-omics diagnostics for early disease detection.
Qiming Venture Partners has invested in 370 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Life Science. The firm invests across 41 different industry categories.
Among tracked funding rounds, Outpace Bio received $144.0M in a Series B round. Qiming Venture Partners's total known invested capital is $11.0B.
Qiming Venture Partners's average investment size is $54.4M across its portfolio of 370 companies.
Recent Qiming Venture Partners portfolio additions include Satellos Bioscience, TigerGraph, Renasant Bio, Elevation Oncology, Leyden Labs. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors